Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

Global sales of neuromodulation systems for the treatment of movement disorders (Parkinson’s disease, essential tremor, and dystonia) and epilepsy, which include implantable deep brain stimulation (DBS) and vagus nerve stimulation (VNS) devices, respectively, are expected to increase at a CAGR of approximately 8.5%, from nearly $1.2bn in 2019 to approximately $1.8bn in 2024.

The highly competitive DBS and VNS segments—which contribute nearly one-third of the global $4.5bn+ neuromodulation market—are significantly underpenetrated, with substantial room for growth. The DBS/VNS markets are being driven by several positive factors, including: a long clinical history with a substantial reduction in debilitating symptoms, strong marketing and surgeon training efforts, and technological innovation (eg new directional lead technologies, precisely targeted stimulation, and therapy customization). The launch of next-generation DBS and VNS systems are further improving outcomes and providing patients with incurable neurological conditions a safe, effective, and long-term device-based therapy alternative.

Note: Despite the severe impact on surgeries in 2020 due to COVID-19, a healthy rebound is expected to occur in both segments due to pent-up demand by patients who have not undergone alternative therapies and suffer from severe, refractory symptoms.

Key competitors in the DBS and VSN markets include:  Medtronic, Boston Scientific, Abbott, LivaNova, and NeuroPace.

This comprehensive medical market and technology report provides:

• overview of neurological disorders and prevalence
• discussion of DBS and VNS technologies, product portfolios
• emerging technologies and innovations
• in-depth market and competitive analyses, including market drivers/limiters, 5-year market forecasts by segment and region, and global/regional market share
• overview of companies, financials, and strategic growth plans

Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. Market forecasts are for the 2019-24 time period.